{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:42Z","timestamp":1793608062016,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129109","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:51:06Z","timestamp":1788785466000},"page":"129109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of vaccine delivery route on immune imprinting in influenza vaccination"],"prefix":"10.1016","volume":"92","author":[{"given":"Vidhi","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashvi","family":"Aryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutwik","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.vaccine.2026.129109_bb0005","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1016\/j.vaccine.2011.04.048","article-title":"Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions","volume":"29","author":"Ortiz","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129109_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110337","article-title":"Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial","volume":"38","author":"Boudreau","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0015","doi-asserted-by":"crossref","first-page":"e4244","DOI":"10.1093\/cid\/ciaa1884","article-title":"Effect of antigenic drift on influenza vaccine effectiveness in the United States-2019-2020","volume":"73","author":"Tenforde","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2026.129109_bb0020","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.48.1900720","article-title":"Influenza imprinting in childhood and the influence on vaccine response later in life","volume":"24","author":"Kelvin","year":"2019","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.02.004","article-title":"Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later","volume":"58","author":"Spangler","year":"2025","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129109_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008109","article-title":"Childhood immune imprinting to influenza a shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics","volume":"15","author":"Gostic","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.129109_bb0035","article-title":"Sequential immunization with live-attenuated chimeric hemagglutinin-based vaccines confers heterosubtypic immunity against influenza A viruses in a preclinical ferret model","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0040","article-title":"M2e\/NP dual epitope-displaying nanoparticles enhance cross-protection of recombinant HA influenza vaccine: a universal boosting strategy","volume":"13","author":"Liu","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129109_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102229","article-title":"Resolving adjuvant mode of action to enhance vaccine efficacy","volume":"77","author":"Turley","year":"2022","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0050","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","article-title":"Effect of vaccine administration modality on immunogenicity and efficacy","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"36","key":"10.1016\/j.vaccine.2026.129109_bb0055","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2015.07.022","article-title":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)\u2014structure, function and species differences","volume":"33","author":"Pabst","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129109_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808527","article-title":"Potentiating lung mucosal immunity through intranasal vaccination","volume":"12","author":"Nelson","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129109_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.111","article-title":"Route of vaccine administration alters antigen trafficking but not innate or adaptive immunity","volume":"30","author":"Ols","year":"2020","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129109_bb0070","article-title":"Novel administration routes, delivery vectors, and application of vaccines based on biotechnologies: a review","volume":"12","author":"Rai","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129109_bb0075","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129109_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038786","article-title":"Original antigenic sin: how original? How sinful?","volume":"11","author":"Yewdell","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0085","doi-asserted-by":"crossref","first-page":"2384192","DOI":"10.1080\/21645515.2024.2384192","article-title":"Immune imprinting: the persisting influence of the first antigenic encounter with rapidly evolving viruses","volume":"20","author":"Maltseva","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"8114","key":"10.1016\/j.vaccine.2026.129109_bb0090","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41586-026-10248-6","article-title":"B cell imprinting in children impairs antibodies to the haemagglutinin stalk","volume":"653","author":"Sun","year":"2026","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.vaccine.2026.129109_bb0095","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1073\/pnas.0912458109","article-title":"Strategies to alleviate original antigenic sin responses to influenza viruses","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129109_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00766-24","article-title":"Influenza virus antibodies inhibit antigen-specific <i>de novo<\/i> B cell responses in mice","volume":"98","author":"Goodwin","year":"2024","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129109_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00169-19","article-title":"Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus","volume":"93","author":"Tesini","year":"2019","journal-title":"J Virol"},{"issue":"316","key":"10.1016\/j.vaccine.2026.129109_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.129109_bb0115","series-title":"B cell imprinting in children impairs antibodies to the haemagglutinin stalk","author":"Sun","year":"2026"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129109_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023910","article-title":"Understanding original antigenic sin in influenza with a dynamical system","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"issue":"1614","key":"10.1016\/j.vaccine.2026.129109_bb0125","first-page":"20120200","article-title":"The antigenic evolution of influenza: drift or thrift?","volume":"368","author":"Wikramaratna","year":"2013","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"10.1016\/j.vaccine.2026.129109_bb0130","series-title":"Assessing evidence of immune imprinting in serological patterns of influenza immune response","author":"Garc\u00eda-Carreras","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129109_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126670","article-title":"Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice","volume":"46","author":"Ma","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129109_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr Opin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41541-024-00875-3","article-title":"Sustained antigen delivery improves germinal center reaction and increases antibody responses in neonatal mice","volume":"9","author":"Lotspeich-Cole","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129109_bb0160","series-title":"Fundamentals and applications of controlled release drug delivery","first-page":"517","article-title":"Fundamentals of vaccine delivery in infectious diseases","author":"\u015eenel","year":"2012"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129109_bb0165","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.vaccine.2011.01.039","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of FluBlok\u00ae trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50\u201364 years of age","volume":"29","author":"Baxter","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-8-251","article-title":"Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus","volume":"8","author":"Harris","year":"2011","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0175","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0264-410X(95)00016-T","article-title":"Human immune responses to influenza virus vaccines administered by systemic or mucosal routes","volume":"13","author":"Moldoveanu","year":"1995","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129109_bb0180","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/infdis\/jiy685","article-title":"Diminished B-cell response after repeat influenza vaccination","volume":"219","author":"Sanyal","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barr\u00eda","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129109_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2017.0022","article-title":"Intranasal administration of whole inactivated influenza virus vaccine as a promising influenza vaccine candidate","volume":"30","author":"Ainai","year":"2017","journal-title":"Viral Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0195","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/vaccines8040572","article-title":"Intranasal delivery of a chitosan-hydrogel vaccine generates nasal tissue resident memory CD8+ T cells that are protective against influenza virus infection","volume":"8","author":"Bedford","year":"2020","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129109_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.06.005","article-title":"Primary nasal influenza infection rewires tissue-scale memory response dynamics","volume":"57","author":"Kazer","year":"2024","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0753-3322(00)89027-7","article-title":"Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review","volume":"54","author":"Boyce","year":"2000","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153195","article-title":"Age dependence of immunity induced by a candidate universal influenza vaccine in mice","volume":"11","author":"Garc\u00eda","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/pt0804081","article-title":"Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination","volume":"8","author":"Garmise","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129109_bb0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129109_bb0225","first-page":"343","article-title":"Skin immunization with influenza vaccines","volume":"386","author":"Skountzou","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2010.07.125","article-title":"Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles","volume":"147","author":"Quan","year":"2010","journal-title":"J Control Release"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129109_bb0235","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1128\/JVI.01849-09","article-title":"Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization","volume":"84","author":"Quan","year":"2010","journal-title":"J Virol"},{"issue":"37","key":"10.1016\/j.vaccine.2026.129109_bb0240","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.vaccine.2015.03.062","article-title":"Opportunities and challenges in delivering influenza vaccine by microneedle patch","volume":"33","author":"Jacoby","year":"2015","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129109_bb0245","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1073\/pnas.0812652106","article-title":"Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge","volume":"106","author":"Zhu","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129109_bb0250","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.129109_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105979","article-title":"Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infection","volume":"230","author":"Yoon","year":"2024","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"29","key":"10.1016\/j.vaccine.2026.129109_bb0265","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1016\/j.vaccine.2007.05.002","article-title":"A dose\u2013response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults","volume":"25","author":"Atmar","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129109_bb0270","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129109_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206521","article-title":"Lymph node follicle-targeting STING agonist nanoshells enable single-shot M2e vaccination for broad and durable influenza protection","volume":"10","author":"Tsai","year":"2023","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1832","article-title":"Recent advancements in single dose slow-release devices for prophylactic vaccines","volume":"15","author":"Ray","year":"2023","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0285","doi-asserted-by":"crossref","DOI":"10.29245\/2578-3009\/2020\/4.1193","article-title":"Implantable vaccines: a solution for immune system manipulation to any antigenic stimulus","volume":"4","author":"Zerva","year":"2020","journal-title":"J Immunol Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0290","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/jbm.a.37203","article-title":"Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity","volume":"109","author":"Saouaf","year":"2021","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.vaccine.2026.129109_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127778","article-title":"Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligand","volume":"65","author":"Hayashi","year":"2025","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129109_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012393","article-title":"Evaluation of a novel intramuscular prime\/intranasal boost vaccination strategy against influenza in the pig model","volume":"20","author":"Avanthay","year":"2024","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.129109_bb0305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2021.03.099","article-title":"Nasal\u2013subcutaneous prime\u2013boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections","volume":"554","author":"Shibuya","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0310","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41467-025-67102-y","article-title":"Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial","volume":"17","author":"Rodr\u00edguez-Guilarte","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2026.129109_bb0320","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/infdis\/jiz017","article-title":"Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection","volume":"219","author":"Eichelberger","year":"2019","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-019-0572-3","article-title":"M2e-based universal influenza vaccines: a historical overview and new approaches to development","volume":"26","author":"Mezhenskaya","year":"2019","journal-title":"J Biomed Sci"},{"issue":"30","key":"10.1016\/j.vaccine.2026.129109_bb0330","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.2004783117","article-title":"Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes","volume":"117","author":"Liao","year":"2020","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00728-5","article-title":"A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses","volume":"8","author":"Liu","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0340","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14760584.2018.1541408","article-title":"Universal influenza vaccines: from viruses to nanoparticles","volume":"17","author":"Wang","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129109_bb0345","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024998118","article-title":"Intranasal vaccination with influenza HA\/GO-PEI nanoparticles provides immune protection against homo-and heterologous strains","volume":"118","author":"Dong","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129109_bb0350","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1039\/D3BM00305A","article-title":"Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles","volume":"11","author":"Nesovic","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.vaccine.2026.129109_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01760","article-title":"AS03- and MF59-adjuvanted influenza vaccines in children","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41541-022-00524-7","article-title":"The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination","volume":"7","author":"Goll","year":"2022","journal-title":"npj Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0365","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/vaccines8030434","article-title":"Influenza A virus vaccination: immunity, protection, and recent advances toward a universal vaccine","volume":"8","author":"Lopez","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-018-0433-5","article-title":"Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes","volume":"25","author":"Stepanova","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2026.129109_bb0375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jconrel.2022.05.017","article-title":"STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant","volume":"347","author":"Gallovic","year":"2022","journal-title":"J Control Release"},{"issue":"497","key":"10.1016\/j.vaccine.2026.129109_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9565","article-title":"The right adjuvant gives T follicular helper cells a boost","volume":"11","author":"Boyle","year":"2019","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129109_bb0385","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129109_bb0390","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2013.0013","article-title":"Mucosal adjuvants for influenza virus-like particle vaccine","volume":"26","author":"Quan","year":"2013","journal-title":"Viral Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129109_bb0395","article-title":"Intradermal vaccination against influenza with a STING-targeted nanoparticle combination adjuvant induces superior cross-protective humoral immunity in swine compared with intranasal and intramuscular immunization","volume":"11","author":"Hernandez-Franco","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129109_bb0400","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/jps.23220","article-title":"Immunogenicity and protection of oral influenza vaccines formulated into microparticles","volume":"101","author":"Shastri","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129109_bb0405","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original antigenic sin: how first exposure shapes lifelong anti\u2013influenza virus immune responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0410","first-page":"15G. 3.1","article-title":"The mouse model for influenza","volume":"13","author":"Matsuoka","year":"2009","journal-title":"Curr Protoc Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129109_bb0415","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model","volume":"5","author":"Fernando","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129109_bb0425","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/pathogens3040845","article-title":"Animal models for influenza viruses: implications for universal vaccine development","volume":"3","author":"Margine","year":"2014","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129109_bb0430","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v13061011","article-title":"Animal models for influenza research: strengths and weaknesses","volume":"13","author":"Nguyen","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129109_bb0435","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1242\/dmm.007823","article-title":"The ferret as a model organism to study influenza A virus infection","volume":"4","author":"Belser","year":"2011","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129109_bb0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/vaccines8020173","article-title":"Immune imprinting in the influenza ferret model","volume":"8","author":"Skarlupka","year":"2020","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0445","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/MMBR.00022-16","article-title":"Complexities in ferret influenza virus pathogenesis and transmission models","volume":"80","author":"Belser","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2026.129109_bb0450","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3389\/fimmu.2019.01694","article-title":"Techniques to study antigen-specific B cell responses","volume":"10","author":"Boonyaratanakornkit","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0455","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41596-023-00930-8","article-title":"Production and use of antigen tetramers to study antigen-specific B cells","volume":"19","author":"Phelps","year":"2024","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129109_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12020169","article-title":"First impressions matter: immune imprinting and antibody cross-reactivity in influenza and SARS-CoV-2","volume":"12","author":"King","year":"2023","journal-title":"Pathogens"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129109_bb0465","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aec3183","article-title":"Childhood immune imprinting shapes cohort and period influenza mortality","volume":"12","author":"Hoffman","year":"2026","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129109_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7030087","article-title":"Comparative immunogenicity of the 2014\u20132015 Northern hemisphere trivalent IIV and LAIV against influenza A viruses in children","volume":"7","author":"Ang","year":"2019","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129109_bb0480","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.35693","article-title":"Immunogenicity and safety of reduced-dose intradermal vs intramuscular influenza vaccines: a systematic review and meta-analysis","volume":"4","author":"Egunsola","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10095","key":"10.1016\/j.vaccine.2026.129109_bb0485","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-021-00353-0","article-title":"Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial","volume":"6","author":"Rouphael","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129109_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1809302","article-title":"Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress","volume":"17","author":"Reis","year":"2026","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129109_bb0500","article-title":"Beyond the needle: innovative microneedle-based transdermal vaccination","volume":"12","author":"Nguyen","year":"2025","journal-title":"Medicines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:41:02Z","timestamp":1793605262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":100,"alternative-id":["S0264410X26009187"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129109","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of vaccine delivery route on immune imprinting in influenza vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129109"}}